9,854 reports of this reaction
2.2% of all Cymbalta reports
#7 most reported adverse reaction
DIARRHOEA is the #7 most commonly reported adverse reaction for Cymbalta, manufactured by Eli Lilly and Company. There are 9,854 FDA adverse event reports linking Cymbalta to DIARRHOEA. This represents approximately 2.2% of all 439,614 adverse event reports for this drug.
Patients taking Cymbalta who experience diarrhoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DIARRHOEA is a less commonly reported adverse event for Cymbalta, but still significant enough to appear in the safety profile.
In addition to diarrhoea, the following adverse reactions have been reported for Cymbalta:
The following drugs have also been linked to diarrhoea in FDA adverse event reports:
DIARRHOEA has been reported as an adverse event in 9,854 FDA reports for Cymbalta. This does not prove causation, but indicates an association observed in post-market surveillance data.
DIARRHOEA accounts for approximately 2.2% of all adverse event reports for Cymbalta, making it a notable side effect.
If you experience diarrhoea while taking Cymbalta, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.